100 likes | 490 Views
Initial monotherapy and combination therapy and hypertension control the first year. Egan BM, Bandyopadhyay D, Shaftman SR, Wagner CS, Zhao Y, Yu-Isenberg KS. Hypertension . 2012;59:1124-1131 . Patient characteristics. 180 Clinical sites – 106 621 patients
E N D
Initial monotherapy and combination therapy and hypertension control the first year Egan BM, Bandyopadhyay D, Shaftman SR, Wagner CS, Zhao Y, Yu-Isenberg KS. Hypertension. 2012;59:1124-1131.
Patient characteristics • 180 Clinical sites – 106 621 patients • Patients included were untreated and uncontrolled for ≥6 months before initial therapy, and had ≥1 year of follow-up data Egan BM, Bandyopadhyay D, Shaftman SR, Wagner CS, Zhao Y, Yu-Isenberg KS. Hypertension. 2012;59:1124-1131.
Main results • The majority of patients completed the year on their initial treatment category • Patients who ended on free combinations included both those on free combinations only and those on ≥2 free-dose medications with a single-pill combination • The single-pill combination group had higher: • Body mass index • Proportion of females • Proportion of patients with stage 2 hypertension • Proportion of patients with BP ≥20/10 mm Hg above goal Egan BM, Bandyopadhyay D, Shaftman SR, Wagner CS, Zhao Y, Yu-Isenberg KS. Hypertension. 2012;59:1124-1131.
Single-pill combination better than free combination Single-pill combination Free combination Monotherapy 68% 59% 59% Control rate Days to control Egan BM, Bandyopadhyay D, Shaftman SR, Wagner CS, Zhao Y, Yu-Isenberg KS. Hypertension. 2012;59:1124-1131.
Conclusion • Hypertensive patients begun on single-pill combinations were 53% more likely than those started on monotherapy to attain BP control in the first year. • Despite starting with higher untreated BP, patients who began treatment with single-pill combinations were more likely to achieve BP control than those started on free combination or monotherapy Greater use of single-pill combinations as initial therapy improves hypertension control and cardiovascular outcomes in the first year of treatment. Egan BM, Bandyopadhyay D, Shaftman SR, Wagner CS, Zhao Y, Yu-Isenberg KS. Hypertension. 2012;59:1124-1131.